SG3 Management’s TG Therapeutics TGTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Hold |
0
| – | – | – | 103 |
|
|
2022
Q4 | – | Hold |
0
| – | – | – | 180 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 237 |
|
|
2022
Q2 | – | Hold |
0
| – | – | – | 435 |
|
|
2022
Q1 | – | Hold |
0
| – | – | – | 700 |
|
|
2021
Q4 | – | Sell |
-5,371
| Closed | -$179K | – | 651 |
|
|
2021
Q3 | $179K | Sell |
5,371
-4,129
| -43% | -$138K | 0.01% | 175 |
|
|
2021
Q2 | $369K | Buy |
9,500
+5,500
| +138% | +$214K | 0.01% | 128 |
|
|
2021
Q1 | $193K | Buy |
+4,000
| New | +$193K | ﹤0.01% | 231 |
|
|
2020
Q4 | – | Sell |
-12,094
| Closed | -$324K | – | 603 |
|
|
2020
Q3 | $324K | Buy |
+12,094
| New | +$324K | 0.01% | 133 |
|
|
2020
Q2 | – | Hold |
0
| – | – | – | 378 |
|
|
2019
Q3 | – | Sell |
-30,000
| Closed | -$260K | – | 263 |
|
|
2019
Q2 | $260K | Buy |
+30,000
| New | +$260K | 0.03% | 43 |
|